Skip to content

IMUX - IMMUNIC, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Immunic Inc

IMUX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IMUXImmunic Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $17.43
52-wk low: $5.06
Prev close: $10.71
Mkt cap: $224.5M
Beta: 1.40
P/B: 1.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$15.9M

MI
Millennium
Israel Englander · Q2 2026 13F
$11.4M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 35.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $224M

Valuation

P/B1.81

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IMUX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $224.45M
Beta: 1.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-138.2%

$1.6M

position

BH

Brevan Howard

Alan Howard · Q2 2026 13F

$356K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IMUX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.80+35.5%

-$1.24 expected

Next report

What the street expects next

EPS expected

-$1.18

-$2.21 to -$0.68

Revenue expected

$0.00

10 analysts

Last 30 days

2up4down

Analysts cutting estimates

Estimate drift

+0.01

Change in 30 days

-138.2%

ROA-66.8%

Growth

Beta1.40